[HTML][HTML] Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors
V Gupta, M Eapen, R Brazauskas, J Carreras… - …, 2010 - ncbi.nlm.nih.gov
Haematologica, 2010•ncbi.nlm.nih.gov
Background Transplantation from an HLA-matched sibling is the treatment of choice for
young patients with acquired severe aplastic anemia. For older patients, the acceptable
upper age limit for transplantation as first-line treatment varies. The current analysis,
therefore, sought to identify age or ages at transplantation at which survival differed.
young patients with acquired severe aplastic anemia. For older patients, the acceptable
upper age limit for transplantation as first-line treatment varies. The current analysis,
therefore, sought to identify age or ages at transplantation at which survival differed.
Abstract
Background
Transplantation from an HLA-matched sibling is the treatment of choice for young patients with acquired severe aplastic anemia. For older patients, the acceptable upper age limit for transplantation as first-line treatment varies. The current analysis, therefore, sought to identify age or ages at transplantation at which survival differed.
ncbi.nlm.nih.gov